Hemanext has committed its resources to the continuing effort of the transfusion medicine community to save lives and improve patient outcomes. The company is dedicated to improving the quality, safety, efficacy, and cost of transfusion therapy.
View Investor Portal for confidential information and updates. Learn about Hemanext ONE technology.
Hemanext Inc. a privately held, US-based medical technology company dedicated to improving the quality, safety, efficacy, and cost of red blood cell (RBC) transfusions, has partnered with Sickle Cell 101 (SC101), a Silicon Valley-based non-profit, to sponsor and promote sickle cell disease (SCD) education.
Hemanext® Inc. Receives CE Mark Certification for Innovative Red Blood Cell (RBC) Processing & Storage System
Company to launch red blood cell (RBC) processing and storage system in select European markets in 2021, with wider distribution in Europe and the Americas in 2022 and future years.
Sickle Cell Disease Association of America, Inc. Launches New Educational Materials to Support Children’s Blood Transfusion
Sickle Cell Disease Association of America, Inc. (SCDAA) and Hemanext Inc., today announced the launch of new educational material to help SCDAA deliver on its mission and meet its goals.
Hemanext Inc., a privately held medical technology company dedicated to improving the quality, safety, efficacy and cost of red blood cell (RBC) transfusions, today announced that it will present four new abstracts on the potential benefits of hypoxic storage of RBCs through its online booth during the American Association of Blood Banks (AABB) Virtual Annual Meeting Oct. 3-5, 2020.
The Thalassaemia International Federation (TIF), a worldwide organization dedicated to ensuring equal access to quality healthcare for every patient with thalassaemia and other hemoglobin disorders across the world, and Hemanext Inc., a privately held medical technology company dedicated to improving patients’ quality of life by delivering a better red blood cell (RBC) replacement therapy, today announced a new strategic alliance on behalf of people living with thalassaemia.
Curated resources for news, contact information, and newsletter sign-up.